Vancouver, Canada-based ICC International Cannabis Corp. completed its planned acquisition of 49.9% of Wayland Group Corp.'s global asset and license portfolio.

The companies entered into a definitive agreement in April.

As part of the agreement, ICC agreed to issue 300 million shares at 43 cents apiece to Ontario-based medical cannabis producer Wayland.

The companies also agreed to enter a three-year supply deal that will provide ICC, a producer of cannabidiol extracts for medical use, with 10,000 kilograms of EU good manufacturing practice certified product yearly.